FR2696093B1 - Composition pharmaceutique contenant du caféate de 3-méthyl-2-butényle et son utilisation dans un traitement contre l'herpès. - Google Patents

Composition pharmaceutique contenant du caféate de 3-méthyl-2-butényle et son utilisation dans un traitement contre l'herpès.

Info

Publication number
FR2696093B1
FR2696093B1 FR9211607A FR9211607A FR2696093B1 FR 2696093 B1 FR2696093 B1 FR 2696093B1 FR 9211607 A FR9211607 A FR 9211607A FR 9211607 A FR9211607 A FR 9211607A FR 2696093 B1 FR2696093 B1 FR 2696093B1
Authority
FR
France
Prior art keywords
methyl
pharmaceutical composition
composition containing
treatment against
against herpes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9211607A
Other languages
English (en)
Other versions
FR2696093A1 (fr
Inventor
Maryvonne Amoros
Francoise Sauvager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JOANNY LABO PHARMA FABI
Original Assignee
JOANNY LABO PHARMA FABI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JOANNY LABO PHARMA FABI filed Critical JOANNY LABO PHARMA FABI
Priority to FR9211607A priority Critical patent/FR2696093B1/fr
Publication of FR2696093A1 publication Critical patent/FR2696093A1/fr
Application granted granted Critical
Publication of FR2696093B1 publication Critical patent/FR2696093B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
FR9211607A 1992-09-29 1992-09-29 Composition pharmaceutique contenant du caféate de 3-méthyl-2-butényle et son utilisation dans un traitement contre l'herpès. Expired - Fee Related FR2696093B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9211607A FR2696093B1 (fr) 1992-09-29 1992-09-29 Composition pharmaceutique contenant du caféate de 3-méthyl-2-butényle et son utilisation dans un traitement contre l'herpès.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211607A FR2696093B1 (fr) 1992-09-29 1992-09-29 Composition pharmaceutique contenant du caféate de 3-méthyl-2-butényle et son utilisation dans un traitement contre l'herpès.

Publications (2)

Publication Number Publication Date
FR2696093A1 FR2696093A1 (fr) 1994-04-01
FR2696093B1 true FR2696093B1 (fr) 1994-12-16

Family

ID=9434006

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9211607A Expired - Fee Related FR2696093B1 (fr) 1992-09-29 1992-09-29 Composition pharmaceutique contenant du caféate de 3-méthyl-2-butényle et son utilisation dans un traitement contre l'herpès.

Country Status (1)

Country Link
FR (1) FR2696093B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793141B1 (fr) * 1999-05-05 2003-08-08 Fabre Pierre Dermo Cosmetique Extrait de bourgeons de peuplier et son association avec le squalane pour son utilisation en tant que medicament anti-inflammatoire et dans un procede de traitement cosmetique

Also Published As

Publication number Publication date
FR2696093A1 (fr) 1994-04-01

Similar Documents

Publication Publication Date Title
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
GB9206736D0 (en) Improvements of organic compounds and their use in pharmaceutical compositions
PT81969A (de) 11beta-phenyl-gonane deren herstellung und diese enthaltende pharmazeutische praparate
HUT75089A (en) Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent
FR09C0055I2 (fr) Composition pharmaceutique comprenant de pioglitazone et du glimepiride pour utilisation dans le traitement du diabete
ITMI920074A0 (it) Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
BR1100824A (pt) Composto e composição farmacêutica
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
DE69333072D1 (de) Topisch anzuwendendes arzneimittel enthaltend hyaluronsäure und nsaids
FR2601875B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol
AU3878895A (en) Use of nitric oxide donors in medicine
ITMI930582A0 (it) Composizione farmeceutiche ad attivita' analgesica
ITMI931325A0 (it) Composizione farmaceutica ad attivita' analgesica
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DK439589D0 (da) Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
FR2618333B1 (fr) Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
FR2696093B1 (fr) Composition pharmaceutique contenant du caféate de 3-méthyl-2-butényle et son utilisation dans un traitement contre l'herpès.
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
AU3752189A (en) Pharmaceutical compositions and use thereof in treating inflammation
ITMI921629A1 (it) Composizioni farmaceutuche ad attivita' antiaggregante e vasodilatatrice
FR2733418B1 (fr) Nouvelles associations comprenant du (-) hydroxycitrate et presentant notamment de nouvelles activites therapeutiques
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
FR2618672B1 (fr) Utilisation dans le traitement de l'acne et de la seborrhee d'une composition contenant un hydroperoxyde
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances

Legal Events

Date Code Title Description
TP Transmission of property
RM Correction of a material error
CA Change of address
ST Notification of lapse